X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 10/02/2025 13:57

Novel MSC-based therapy provides hope for ocular GVHD treatment

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues.

Articles similaires

New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease

news.medical.net - 24/Jan 10:02

An international task force of medical experts recently proposed major revisions to the way doctors measure treatment success for a common–and often...

Study provides a new paradigm for managing transplant‑related immune complications

news.medical.net - 16/Jan 18:32

Acute graft-versus-host disease (aGVHD) is one of the most serious complications after allogeneic hematopoietic stem cell transplantation...

New cancer drugs and cell disease treatment approved for use in Scotland

news.stv.tv - 19/Jan 11:30

A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.

New Stem Cell Therapy Uses DNA Compass for Stroke Recovery

medindia.net - 15/Jan 18:12

Scientists transplanted bhuman stem cells that use internal genetic code to navigate and rebuild damaged cells in the medlinkstroke/medlink...

New Stem Cell Therapy Uses DNA Compass for Stroke Recovery

medindia.net - 15/Jan 18:12

Scientists transplanted bhuman stem cells that use internal genetic code to navigate and rebuild damaged cells in the medlinkstroke/medlink...

New Stem Cell Therapy Uses DNA Compass for Stroke Recovery

medindia.net - 15/Jan 18:11

Stem cells use inbuilt map for genetic navigation to repair stroke damage. Explore how brain connections and motor skills are restored.

What is Anktiva? Saudi Arabia approves new lung cancer therapy first in world

times of india - 17/Jan 12:56

Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer cells. The Saudi Food and...

Study identifies tumour progression pattern as predictor of survival after first-line NSCLC therapy

oncologynews.com.au - 27/Jan 16:10

New Australian research published in Cancer Letters suggests that how advanced non-small cell lung cancer (NSCLC) progresses after first-line...

Study identifies tumour progression pattern as predictor of survival after first-line NSCLC therapy

oncologynews.com.au - 27/Jan 16:10

New Australian research published in Cancer Letters suggests that how advanced non-small cell lung cancer (NSCLC) progresses after first-line...

Inhalable therapy aims for one-two punch against advanced melanoma

oncologynews.com.au - 23/Jan 06:13

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the body’s own cells. Cancer...